Wikipedia -WSS

Wikipedia

author：fashion 2025-09-30 16:24:30 - browse：779

An AstraZeneca sign at ESMO in Madrid. — An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Abbott's new stent may help patients with peripheral artery disease

focus

hotspot

WSS

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

BIO selects John Crowley as new CEO

STAT reporters are Pulitzer Prize finalists for investigative reporting

Despite FDA concern, risk that CAR

ReNAgade cuts staff seven months after raising $300 million

ALS treatment from Biogen, Ionis fails in study

focus

Wikipedia

Wikipedia

Psychedelics group wrestles with new pharma identity

The EPA's new lead rule: How one expert crunched the numbers

23andMe had bad news about my health. I wish a person had delivered it

ReNAgade cuts staff seven months after raising $300 million

Peter Hotez and the public health issue of online harassment

BIO selects John Crowley as new CEO

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Sports medicine is finally prioritizing gender equality

Obesity drug from Roche shows promise in early study

focus

BIO selects John Crowley as new CEO

Organ aging and disease risk measured by new blood test

U.K. Biobank has 500,000 peoples' genome sequences available

Obesity drug from Roche shows promise in early study

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Fertility clinic egg and embryo storage is a disaster

focus

hotspot

knowledge

Wikipedia